CoChat

Endothelin-1 enhances fibrogenic gene expression, but does not promote DNA synthesis or apoptosis in hepatic stellate cells

Open access
Koda, Masahiko, Bauer, Michael, Krebs, Anja, Hahn, Eckhart G, Schuppan, Detlef, Murawaki, Yoshikazu · 2006 · Comparative Hepatology

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Abstract

BACKGROUND: In liver injury, the pool of hepatic stellate cell (HSC) increases and produces extracellular matrix proteins, decreasing during the resolution of fibrosis. The profibrogenic role of endothelin-1 (ET-1) in liver fibrosis remains disputed. We therefore studied the effect of ET-1 on proliferation, apoptosis and profibrogenic gene expression of HSCs. RESULTS: First passage HSC predominantly expressed endothelin A receptor (ETAR) mRNA and 4th passage HSC predominantly expressed the endothelin B receptor (ETBR) mRNA. ET-1 had no effect on DNA synthesis in 1st passage HSC, but reduced DNA synthesis in 4th passage HSC by more than 50%. Inhibition of proliferation by endothelin-1 was abrogated by ETBR specific antagonist BQ788, indicating a prominent role of ETBR in growth inhibition. ET-1 did not prevent apoptosis induced by serum deprivation or Fas ligand in 1st or 4th passage HSC. However, ET-1 increased procollagen alpha1(I), transforming growth factor beta-1 and matrix metalloproteinase (MMP)-2 mRNA transcripts in a concentration-dependent manner in 1st, but not in 4th passage HSC. Profibrogenic gene expression was abrogated by ETAR antagonist BQ123. Both BQ123 and BQ788 attenuated the increase of MMP-2 expression by ET-1. CONCLUSION: We show that ET-1 stimulates fibrogenic gene expression for 1st passage HSC and it inhibits HSC proliferation for 4th passage HSC. These data indicate the profibrogenic and antifibrogenic action of ET-1 for HSC are involved in the process of liver fibrosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1476-5926-5-5

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 The gene expression of ETAR and ETBR in early- and late-passage HSC. A: The gene expression of ETAR and ETBR in 1st and 4th passage HSC. B: the relative expression ratio of ETAR to ETBR in 1st and 4th passage HSC. HSC were plated on 25 cm2 dishes at a density of 1.0 × 105 cells/dish in DMEM containing 10% FCS. After confluence, cells were washed with PBS and placed in DMEM with 0.125% FCS for 24 hours. RNA isolation and real time PCR using SYBR Green were performed according to Material and Methods. Data were normalized to GAPDH mRNA levels. Results are given as mean ± SD (n = 5). *: p < 0.05.
Figure 1 The gene expression of ETAR and ETBR in early- and late-passage HSC. A: The gene expression of ETAR and ETBR in 1st and 4th passage HSC. B: the relative expression ratio of ETAR to ETBR in 1st and 4th passage HSC. HSC were plated on 25 cm2 dishes at a density of 1.0 × 105 cells/dish in DMEM containing 10% FCS. After confluence, cells were washed with PBS and placed in DMEM with 0.125% FCS for 24 hours. RNA isolation and real time PCR using SYBR Green were performed according to Material and Methods. Data were normalized to GAPDH mRNA levels. Results are given as mean ± SD (n = 5). *: p < 0.05.CC BY · PubMed Central
Figure 2 Effect of ET-1 on DNA synthesis and proliferation in HSC. A: Effect of ET-1 on DNA synthesis of 1st passage HSC. BrdU incorporation into DNA was measured in 8 × 103 HSC during 48 h and at different concentrations of FCS. Absorbance values of controls were set as 100% for each concentration of FCS and values normalized to the respective control culture levels. Results were means ± SD (n = 8). There was no effect of ET-1 on the proliferation of 1st passage HSC. B: Inhibitory effect of ET-1 on the proliferation of 4th passage HSC. BrdU incorporation into DNA was measured in 8x103 HSC during 48 hours at different concentrations of ET-1 or the ETBR agonist S6c with 10% FCS. The ETAR antagonist, BQ123, or the ETBR antagonists, BQ788, were added at 10-6 M in the presence of 10-6 M of ET-1. Results are given as mean ± SD (n = 8). Absorbance values of controls were set as 100% and values for cultures under the influence of each concentration of ET-1 or S6c are shown. *p < 0.05, **p < 0.01 vs control, ## p < 0.01 vs ET -1 10-6 M.
Figure 2 Effect of ET-1 on DNA synthesis and proliferation in HSC. A: Effect of ET-1 on DNA synthesis of 1st passage HSC. BrdU incorporation into DNA was measured in 8 × 103 HSC during 48 h and at different concentrations of FCS. Absorbance values of controls were set as 100% for each concentration of FCS and values normalized to the respective control culture levels. Results were means ± SD (n = 8). There was no effect of ET-1 on the proliferation of 1st passage HSC. B: Inhibitory effect of ET-1 on the proliferation of 4th passage HSC. BrdU incorporation into DNA was measured in 8x103 HSC during 48 hours at different concentrations of ET-1 or the ETBR agonist S6c with 10% FCS. The ETAR antagonist, BQ123, or the ETBR antagonists, BQ788, were added at 10-6 M in the presence of 10-6 M of ET-1. Results are given as mean ± SD (n = 8). Absorbance values of controls were set as 100% and values for cultures under the influence of each concentration of ET-1 or S6c are shown. *p < 0.05, **p < 0.01 vs control, ## p < 0.01 vs ET -1 10-6 M.CC BY · PubMed Central
Figure 3 HSC apoptosis. A :Apoptotic rate of 1st and 4th passage HSC induced by different concentrations of Fas-ligand. Apoptotic rate of HSC was measured after HSC were incubated in DMEM with 0.125% FCS containing Fas-ligand at different concentrations for 24 hours. Results are given as mean ± SD (n = 4). **: p < 0.01 vs control. B :Effect of ET-1 and ET receptor antagonists on Fas-induced apoptosis of 1st and 4th passage HSC. HSC in DMEM containing 0.125% FCS were incubated with ET -1 alone at 10-8 M or 10-6 M with or without Fas-ligand (50 ng/ml), or with ET-1 (10-6 M), FasL and the ETAR antagonist BQ123 or the ETBR antagonist BQ788 (both at 10-6 M). Results are given as mean ± SD (n = 8).
Figure 3 HSC apoptosis. A :Apoptotic rate of 1st and 4th passage HSC induced by different concentrations of Fas-ligand. Apoptotic rate of HSC was measured after HSC were incubated in DMEM with 0.125% FCS containing Fas-ligand at different concentrations for 24 hours. Results are given as mean ± SD (n = 4). **: p < 0.01 vs control. B :Effect of ET-1 and ET receptor antagonists on Fas-induced apoptosis of 1st and 4th passage HSC. HSC in DMEM containing 0.125% FCS were incubated with ET -1 alone at 10-8 M or 10-6 M with or without Fas-ligand (50 ng/ml), or with ET-1 (10-6 M), FasL and the ETAR antagonist BQ123 or the ETBR antagonist BQ788 (both at 10-6 M). Results are given as mean ± SD (n = 8).CC BY · PubMed Central
Figure 4 Effect of ET-1 on procollagen type I and TIMP-1 transcript levels of 1st and 4th passage HSC. Cells were incubated without or with 10-8 M or 10-6 M ET-1 for 48 hours. Total RNA from HSC was reverse transcribed and transcript levels of procollagen α1(I) and TIMP-1 were determined by real time quantitative PCR based on the Taqman technology. Data were normalized to GAPDH mRNA levels. Results are given as mean ± SD (n = 4). **: p < 0.01 vs controls.
Figure 4 Effect of ET-1 on procollagen type I and TIMP-1 transcript levels of 1st and 4th passage HSC. Cells were incubated without or with 10-8 M or 10-6 M ET-1 for 48 hours. Total RNA from HSC was reverse transcribed and transcript levels of procollagen α1(I) and TIMP-1 were determined by real time quantitative PCR based on the Taqman technology. Data were normalized to GAPDH mRNA levels. Results are given as mean ± SD (n = 4). **: p < 0.01 vs controls.CC BY · PubMed Central
Figure 5 Effect of ET receptor antagonists on procollagen α1(I) mRNA expression of 1st passage HSC. Cells were stimulated with 10-6 M ET-1 in the absence or presence of the ETAR antagonist BQ123 (10-6 M) or the ETBR antagonist BQ788 (10-6 M) for 48 hours. The mRNA levels were determined by real time quantitative PCR. Results are given as mean ± SD (n = 4). **p < 0.01 vs control, ## p < 0.01 vs ET-1 (10-6 M).
Figure 5 Effect of ET receptor antagonists on procollagen α1(I) mRNA expression of 1st passage HSC. Cells were stimulated with 10-6 M ET-1 in the absence or presence of the ETAR antagonist BQ123 (10-6 M) or the ETBR antagonist BQ788 (10-6 M) for 48 hours. The mRNA levels were determined by real time quantitative PCR. Results are given as mean ± SD (n = 4). **p < 0.01 vs control, ## p < 0.01 vs ET-1 (10-6 M).CC BY · PubMed Central
Figure 6 Effect of ET-1 on TGFβ-1 and MMP-2 transcript levels of 1st passage HSC and influence of the ET receptor antagonists. Cells were stimulated with 10-6 M ET-1 in absence or presence of the ETAR antagonist BQ123 (10-6 M) or the ETBR antagonist BQ788 (10-6 M). TGFβ-1 and MMP-2 transcript levels were determined by real time quantitative PCR, using Taqman technology, and data were normalized to GAPDH mRNA. Results are given as mean ± SD (n = 4). **: p < 0.01, *: p < 0.05 vs controls, ## p < 0.01 vs ET-1 (10-6 M).
Figure 6 Effect of ET-1 on TGFβ-1 and MMP-2 transcript levels of 1st passage HSC and influence of the ET receptor antagonists. Cells were stimulated with 10-6 M ET-1 in absence or presence of the ETAR antagonist BQ123 (10-6 M) or the ETBR antagonist BQ788 (10-6 M). TGFβ-1 and MMP-2 transcript levels were determined by real time quantitative PCR, using Taqman technology, and data were normalized to GAPDH mRNA. Results are given as mean ± SD (n = 4). **: p < 0.01, *: p < 0.05 vs controls, ## p < 0.01 vs ET-1 (10-6 M).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 41 references

Cited by

See all 20

Metadata

Authors
Koda, M., Bauer, M., Krebs, A., Hahn, E. G., Schuppan, D., & Murawaki, Y.
Affiliations
  • Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
  • Beth Israel Deaconess Medical Center (US)
  • Tottori University (JP)
Corresponding author
Koda, Masahiko
Venue
Comparative Hepatology
Published
2006-10-24
Volume
5
Issue
1
Pages
5-5
ISSN
1476-5926 (ISSN-L)
OpenAlex
W2120648121
Cited by
17
References
41
Citations by year
2025: 1 · 2024: 1 · 2023: 1 · 2021: 3 · 2017: 1 · 2016: 1 · 2014: 1 · 2012: 1
FWCI
0.99
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/2.0 (tdm)
Locations
  • Comparative Hepatology (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Keywords
endothelin-1, hepatic stellate cells, liver fibrosis, ETA receptor, endothelin B receptor, cell proliferation, apoptosis, fibrogenic gene expression, type I procollagen, TGF-β1, MMP-2, BQ-123, BQ-788, extracellular matrix

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Endothelin-1 enhances fibrogenic gene expression, but does not promote DNA synthesis or apoptosis in hepatic stellate cells. https://app.cochat.ai/papers/10.1186/1476-5926-5-5
The paper
Koda, M., Bauer, M., Krebs, A., Hahn, E. G., Schuppan, D., & Murawaki, Y. (2006). Endothelin-1 enhances fibrogenic gene expression, but does not promote DNA synthesis or apoptosis in hepatic stellate cells. Comparative Hepatology. https://doi.org/10.1186/1476-5926-5-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.